Faculty, staff, trainees and students came together to share educational research and best teaching practices during Feinberg’s 14th annual Medical Education Day on October 15.
Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune system responds to the tumor, according to a study published in the Proceedings of the National Academy of Sciences.
People assigned male at birth who belong to a sexual or gender minority group are twice as likely to use methamphetamine following an HIV diagnosis, according to a study published in the Proceedings of the National Academy of Sciences.
Stephen Freeman, a fourth-year MD/MPH student at Feinberg, has been selected to participate in the Pisacano Scholars Leadership Program, a highly competitive professional development and scholarship opportunity given to exceptional future leaders in family medicine.
Patients receiving palliative care via telehealth report similar quality-of-life scores compared to those who had in-person care, according to a multicenter clinical trial recently published in JAMA.
A team of international scientists has uncovered the genetic underpinnings of a rare, inherited autoimmune disorder, according to a study recently published in Science Translational Medicine.
Jeffrey Gordon, MD, a distinguished university professor at Washington University in St. Louis often referred to as the “father of microbiome research,” and recipient of the 2024 Mechthild Esser Nemmers Prize in Medical Science, visited Feinberg’s campus to deliver the keynote lecture on September 30.
Northwestern Medicine scientists have developed a more effective method of delivering a cutting-edge cancer treatment, according to findings published in the journal ACS Nano.
Northwestern Medicine scientists have developed a new way to measure heart contraction and electrical activity in engineered human heart tissues, according to findings published in Science Advances.
Harnessing the body’s own B-cells to fight tumors may be a promising treatment for glioblastoma, according to a Northwestern Medicine study recently published in the Journal of Clinical Investigation.